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Abstract Recently, the increased use of monocyclic
non-steroidal anti-inflammatory drugs has resulted in
their presence in the environment. This may have
potential negative effects on living organisms. The
biotransformation mechanisms of monocyclic non-
steroidal anti-inflammatory drugs in the human body
and in other mammals occur by hydroxylation and
conjugation with glycine or glucuronic acid.
Biotransformation/biodegradation of monocyclic
non-steroidal anti-inflammatory drugs in the environ-
ment may be caused by fungal or bacterial microor-
ganisms. Salicylic acid derivatives are degraded by
catechol or gentisate as intermediates which are
cleaved by dioxygenases. The key intermediate of
the paracetamol degradation pathways is hydroqui-
none. Sometimes, after hydrolysis of this drug, 4-
aminophenol is formed, which is a dead-end metabo-
lite. Ibuprofen is metabolized by hydroxylation or
activation with CoA, resulting in the formation of
isobutylocatechol. The aim of this work is to attempt
to summarize the knowledge about environmental risk
connected with the presence of over-the-counter anti-
inflammatory drugs, their sources and the biotransfor-
mation and/or biodegradation pathways of these
drugs.
Keywords Monocyclic non-steroidal anti-inflammato-
ry drugs . Toxicity . Biodegradation .Microorganisms
1 Introduction
In an age of high level care of human health, many
pharmaceuticals are commonly used to cure or prevent
diseases and other ailments, such as headache, muscle
pain, or inflammatory conditions. Presently, over-the-
counter drugs are very popular, especially over-the-
counter monocyclic and polycyclic non-steroidal anti-
inflammatory drugs (NSAIDs). Among these drugs, the
most popular and the most often used are monocyclic
NSAIDs, such as ibuprofen, acetaminophen, and
salicylic acid (and its derivatives, like mesalazine), due
to their availability (Ziylan and Ince 2011). For exam-
ple, the yearly intake of ibuprofen is up to 300 t in
Germany, 162 t in England, and 58 t in Poland
(Sosnowska et al. 2009; Guzik et al. 2013a). In the
USA during 2001–2005, about 29 billion doses of para-
cetamol in all forms were sold (Li et al. 2014). The high
intake of these widely available drugs may lead to their
or their metabolites’ presence in the environment. In
connection with the presence of NSAIDs in the envi-
ronment, there is a risk of long-term exposure, causing
chronic toxic effect in organisms living there. This may
cause negative effects for living creatures and the accu-
mulation of drugs or their metabolites in the food chain
(Carlsson et al. 2006; Sosnowska et al. 2009). Current
knowledge about the microbial metabolism of non-
steroidal anti-inflammatory drugs is still very little, and
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the fact that we can find them in the environment sug-
gests that sewage treatment plants are not currently
adapted to completely remove these drugs before they
reach the environment. These drugs and their metabo-
lites are found in wastewater influent and effluent from
wastewater treatment plants. For example, in Germany,
acetylsalicylic acid was detected in the sewage effluents
at 0.22 μg/L (Heberer 2002) and paracetamol was de-
tected in groundwater used as a source of public drink-
ing water in California at 1.89 μg/L (Li et al. 2014).
Observed metabolites are formed as a result of the
metabolism by activated sludge microorganisms or en-
ter the treatment plants as the human body biotransfor-
mation products with municipal wastewater (Buser et al.
1999; Zwiener et al. 2002; Marco-Urrea et al. 2009;
Ziylan and Ince 2011). The fate of medicines, including
monocyclic NSAIDs, in the natural environmental is
still less known. The main aim of this work is a compi-
lation of the actual knowledge about sources and risks
connected with the presence of monocyclic non-
steroidal anti-inflammatory drugs in the environment.
Moreover, authors describe microbiological degradation
of the three most widespread painkillers, antipyretic and
anti-inflammatory and over-the-counter drugs—
acetylsalicylic acid, paracetamol, and ibuprofen.
2 Sources of Pharmaceuticals in the Environment
The development of modern analytical methods makes
it possible to detect NSAIDs in the environment. Con-
sidering the high intake of drugs, it may be assumed that
this has an impact on the presence of pharmaceuticals in
wastewaters and surface waters. The main sources of
drugs that reach the environment are excreted in non-
metabolized form or slightly modified, i.e., hydroxylat-
ed, conjugated, and disposed of through the toilet (Buser
et al. 1999; Heberer 2002; Khan and Ongerth 2002;
Zwiener et al. 2002; Metcalfe et al. 2004). Nearly half
of respondents declared the disposal of medications in
the household trash. That is why the presence of phar-
maceuticals is expected in the landfill leachate or
leachate-contaminated groundwater (Kuspis and
Krenzelok 1996; Musson and Townsend 2009). Hospi-
tals’ wastewaters and discharges from pharmaceutical
production also constitute a significant source of phar-
maceuticals in the environment. In many countries,
hospitals and pharmaceutical factories do not have sep-
arate wastewater treatment plants (WWTP); therefore,
these contaminants pass into the general wastewater
treatment system (Metcalfe et al. 2004). The burdened
sewage flows into WWTPs, but not all NSAIDs are
removed in biological sewage treatment with activated
sludge. Drug detection in WWTP effluent confirmed
inadequacy of wastewater treatment plants to complete-
ly removing these pollutants from sewage (Ternes 1998;
Buser et al. 1999; Tixier et al. 2003; Lee et al. 2005;
Gómez et al. 2007; Salgado et al. 2010). Consequently,
this leads to the detection of drugs even in surface waters
such as lakes or rivers (Winkler et al. 2001; Dębska et al.
2005; Roberts and Thomas 2006; Vieno et al. 2006;
Togola and Budzinski 2008; Pailler et al. 2009). Addi-
tionally, Kolpin et al. (2004) observed an increased
concentration of drugs in downstream, above places of
outflows from WWTP.
3 Environmental Risk of Monocyclic Non-Steroidal
Anti-Inflammatory Drugs
Although NSAIDs are observed in the environment in
low concentrations, there is little known about the long-
term effects of low concentrations of these drugs on
living organisms. The most data about toxicity of ibu-
profen, paracetamol, and acetylsalicylic acid are based
on acute toxicity and short-term chronic toxicity tests
(Table 1). In acute toxicity tests, high concentrations of
substances that may result in unrealistic effects are usu-
ally used. In many cases, metabolites of drugs are not
taken into account in toxicity tests; therefore, it is diffi-
cult to evaluate the real risk of NSAIDs and their me-
tabolites on the environment (Webb 2004). Marco-
Urrea et al. (2009), using Microtox toxicity test with
Photobacterium phosphoreum as a tested organism,
proved that hydroxylated derivatives of ibuprofen
(which was also found in sewage and surface waters)
are more toxic than the original compound. Pomati et al.
(2004) showed that even microgram per liter concentra-
tion of ibuprofen can influence the growth of aquatic
phototrophs. For example, Lemna minor exhibited inhi-
bition of growth after 7-day exposure to low concentra-
tion of ibuprofen. Under these conditions, the little effect
on abscisic acid production was also observed (Pomati
et al. 2004; Brausch et al. 2012; Murdoch and Hay
2013). High sensitivity to ibuprofen was also found for
phytoplankton. Depending on tested organisms, EC50
value was between 1 and 315 mg/L after 72–120-h
exposition to this drug (Brausch et al. 2012).
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After 14 days of exposure of Daphnia magna to
ibuprofen at concentration of 20, 40, and 80 mg/L,
significant effects in the total reproduction of daphnias
were observed. Reproduction decreased with the in-
crease of the drug concentration and totally stopped at
80mg/L. Additionally, the time of first reproductionwas
delayed in a concentration of 40 mg/L. A low concen-
tration of ibuprofen within the range of 1–100 ng/L
caused a decrease in the activity of Gammarus pulex.
This is very important information, because this con-
centration range of ibuprofen corresponds more to the
concentration in the environment (de Lange et al. 2006).
Pounds et al. (2008) showed some chronic effects of
ibuprofen on mollusc Planorbis carinatus in the drug
concentrations 0.41, 1.02, 2.43, and 5.36 mg/L. In the
lowest dose, the authors did not observe snails laying
eggs. A dose of ibuprofen at 5.36 mg/L caused an
inhibition of egg hatching (Pounds et al. 2008). Han
Table 1 Toxicity of selected monocyclic NSAIDs
Organism Drug Duration Concentration (mg/L) References
Daphnia magna ASA 24 h EC50 1468 Lilius et al. (1994)
Artemia salina ASA 24 h EC50 382 Calleja et al. (1994)
Streptocephalus proboscideus ASA 24 h EC50 178 Calleja et al. (1994)
Daphnia magna ASA 24 h EC50 168 Calleja et al. (1994)
Brachionus calyciflorus ASA 24 h EC50 141 Calleja et al. (1994)
Desmodesmus subspicatus ASA 24 h EC50 106.7 Cleuvers (2004)
Daphnia magna ASA 24 h EC50 88.1 Cleuvers (2004)
Daphnia magna Ibuprofen 48 h EC50 51.4 Han et al. (2010)
Moina macrocopa Ibuprofen 48 h EC50 72.6 Han et al. (2010)
Keletonema coststum Ibuprofen 96 h EC50 7.1 Halling-Sorensen et al. (1998)
Daphnia magna Ibuprofen 48 h EC50 9.06 Halling-Sorensen et al. (1998)
Lepomismacrochirus Ibuprofen 96 h EC50 173 Halling-Sorensen et al. (1998)
Thamnocephalus platyurus Ibuprofen 24 h EC50 19.59 Kim et al. (2009)
Oryzias latipes Ibuprofen 96 h EC50 >100 Kim et al. (2009)
Hydra attenuata Ibuprofen 96 h LC50 22.36 Quinn et al.(2008)
Hydra attenuata Ibuprofen 96 h EC50 1.65 Quinn et al. (2008)
Daphnia magna Ibuprofen 24 h EC50 101.2 Cleuvers (2004)
Desmodesmus subspicatus Ibuprofen 24 h EC50 343.2 Cleuvers (2004)
Artemia salina Paracetamol 24 h EC50 577 Calleja et al.(1994)
Daphnia magna Paracetamol 24 h EC50 55.5 Calleja et al. (1994)
Brachionus calyciflorus Paracetamol 24 h EC50 5306 Calleja et al. (1994)
Daphnia magna Paracetamol 24 h EC50 13 Kühn et al. (1989))
Daphnia magna Paracetamol 48 h EC50 9.2 Kühn et al. (1989))
Daphnia magna Paracetamol 24 h EC50 293 Henschel et al. (1997)
Daphnia magna Paracetamol 48 h EC50 50 Henschel et al. (1997)
Brachydanio rerio Paracetamol 48 h EC50 378 Henschel et al. (1997)
Scenedesmus subspicatus Paracetamol 24 h EC50 134 Henschel et al. (1997)
Daphnia magna SA 24 h EC50 230 Wang and Lay (1989)
Daphnia magna SA EC50 118 Henschel et al. (1997)
Brachydanio rerio SA 48 h EC50 37 Henschel et al. (1997)
Scenedesmus subspicatus SA 72 h EC50 >100 Henschel et al. (1997)
SA salicylic acid, ASA acetylsalicylic acid (aspirin), ND no data
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et al. (2010) also observed a delay inOryzias latipes egg
hatching after exposure to 0.1 μg/L of ibuprofen. After
120 days of ibuprofen exposure, the survival of fish was
also significantly lower when compared to the control
population (Han et al. 2010). The obtained results are
significant, because the drug concentration used in the
experiment is observed in the environment (Dębska
et al. 2005; Pailler et al. 2009).
Wu et al. (2012) described p-aminophenol as a major
metabolite of paracetamol metabolism in microbes. 4-
Aminophenol is one of the most toxic phenols, which
causes the kidney or the liver damage (Newton et al.
1982; Song and Chen 2001). Li et al. (2014) observed
the appearance of N-acetyl-p-benzoquinone imine
(NAPQI) during biodegradation of acetaminophen in
soil. Additionally, the increased sorption of paracetamol
in soil biosolids was observed, which may cause a
decrease of acetaminophen mineralization. Simulta-
neously, it may affect the half-life of drugs in the envi-
ronment (Li et al. 2014).
N-acetyl-p-benzoquinone imine is also one of the
first phase metabolites of paracetamol detoxification in
humans, excreted as a glutathione conjugate with urine
(Tsikas et al. 2011; Li et al. 2014). It is defined as highly
hepatotoxic (Bender andMacCrehan 2006; Hinson et al.
2010; Tsikas et al. 2011). Bender et al. (2004) suggest
that NAPQI may be a potent inhibitor of human topo-
isomerase IIα.
Toxicological research conducted in the presence of
high concentration of NSAIDs does not provide infor-
mation about the influence of long-term exposure to low
concentration of drugs. The answer to this question may
be provided only by long-term research of many gener-
ations of aquatic organisms living in the presence of low
drug concentration (Rzepa 2009).
4 Acetylsalicylic Acid Biodegradation
by Microorganisms
In humans and animals, acetylsalicylic acid is immedi-
ately hydrolyzed to salicylic acid which can be removed
from the body unchanged or in the form of conjugates
with glycine (as a salicyluric acid) or with glucuronic
acid, or hydroxylated at the C-5 position of the ring to
gentisate (de Gaetano et al. 1985; Ingelman-Sundberg
et al. 1991; Paterson et al. 2008). Apart from excretion
from human and animal organisms, salicylic acid is a
widespread molecule in plants. It plays a role in several
physiological processes, like stomatal closure, flower
induction, heat production and, most of all, its main
function is defense against pathogen attack (Verberne
et al. 2000). If we take this into consideration, it is not
strange that in nature, there are effective salicylate deg-
radation mechanisms. Many bacterial strains, like Mi-
crococcus, Sphingomonas, Amycolatopsis, Streptomy-
ces, Pseudomonas, Alcaligenes, Pseudoramibacter,
Rhodococcus (Chakrabarty 1972; Shamsuzzaman and
Barnsley 1974; Haribabu et al. 1984; Grund et al. 1990;
Grund et al. 1992; Civilini et al. 1999; Hintner et al.
2001; Ishiyama et al. 2004; Deveryshetty et al. 2007;
Jouanneau et al. 2007; Silva et al. 2007; Lanfranconi
et al. 2009) and fungi, like Sclerotinia, Trichosporon,
Aspergillus, Fusarium, Rhodotorula, Cryptococcus
(Anderson and Dagley 1980; Kuswandi and Roberts
1992; Middelhoven 1993; Iwasaki et al. 2009; Qi et al.
2012; Penn and Daniel 2013) are capable of degrading
salicylate (Table 2) via a few catabolic pathways.
The strategy for degradation of aromatic structure
comprises hydroxylation and cleavage of the aromatic
ring. Hydroxylation into the dihydroxylated intermedi-
ates, the first step in the oxidative degradation of aro-
matic compounds, is catalyzed by oxygenases belong-
ing to three groups: hydroxylating dioxygenases,
activated-ring monooxygenases, or nonactivated-ring
monooxygenases. As a result of hydroxylation, the key
intermediates such as catechol, protocatechuic acid,
hydroxyquinol, or gentisic acid are formed. These prod-
ucts are substrates for ring-cleaving dioxygenases. Sa-
licylates are mainly transformed to catechol and
gentisate, which are cleaved in the next step by
dioxygenases from two groups—intradiol or extradiol
(Guzik et al. 2013b; Guzik et al. 2014).
Two of the most important enzymes involved in
salicylate decomposition are salicylate 1-hydroxylase
and salicylate 5-hydroxylase (monooxygenases). Salic-
ylate monooxygenases belong to one of the three groups
of hydroxylating oxygenases—activated-ring
monooxygenases (Wojcieszyńska et al. 2011). The gen-
eral structure of these groups includes a three-
component protein with separate functional units: reduc-
tase with a flavin cofactor, ferrodoxin with a Rieskie-
type iron-sulfur cluster [2Fe-2S] and hexamer-built
α3β3terminal oxygenase with [2Fe-2S] a cluster and
one nonheme iron(II) per α subunit (Mason and
Cammack 1992; Bertini et al. 1996). These catalytic
proteins are able to insert one atom of molecular oxygen
into the structure of the aromatic ring, simultaneously
355 Page 4 of 13 Water Air Soil Pollut (2015) 226: 355
Table 2 Microorganisms degrading selected monocyclic NSAIDs
Strain Drug Concentration References
Pseudomonas putida R1 SA 10 mM Chakrabarty (1972)
Acinetobacter lwoffii ASA 2.77 mM Grant (1971)
Amycolatopsis rugosa DSM 43387 SA ND Grund et al. (1990)
Amycolatopsis rugosa DSM 43388 SA ND Grund et al. (1990)
Streptomyces niger DSM 40302 SA ND Grund et al. (1990)
Streptomyces olivaceiscloticus DSM 40595 SA ND Grund et al. (1990)
Rhodococcus sp. B4 SA ND Grund et al. (1992)
Pseudaminobacter salicylatoxidans B12 SA 5 mM Hintner et al. (2001)
Pseudomonas sp. SA 3.5 mM Shamsuzzaman and Barnsley (1974)
Pseudomonas aeruginosa 2NR SA ND Civilini et al. (1999)
Streptomyces sp. WA46 SA 7.24 mM (on agar plate) Ishiyama et al. (2004)
Rhodococcus ruber IEGM 77 ASA 1.38–2.77 mM Ivshina et al. (2006)
Pseudomonas sp. PPD SA ND Deveryshetty et al. (2007)
Alcaligenes sp. PPH SA ND Deveryshetty et al. (2007)
Sphingomonas sp. CHY-1 SA 0.5–1 mM Jouanneau et al. (2007)
Pseudomonas fluorescens HK44 SA 0.18–1.45 mM Silva et al. (2007)
Trichosporon cutaneum SA ND Anderson and Dagley (1980)
Aspergillus nidulans SA 10 mM Kuswandi and Roberts (1992)
Fusarium graminearum SA 0.1–20 mM Qi et al. (2012)
Sclerotinia sclerotiorum SA 1–10 mM Penn and Daniel (2013)
Trichosporon moniliiformeWU-0401 SA 70 mM Iwasaki et al. (2009)
Rhodococcus spp. Paracetamol 1.65–3.31 mM Ivshina et al. (2006)
Delftia tsuruhatensis Paracetamol 0.007 mM de Gusseme et al. (2011)
Pseudomonas aeruginosa Paracetamol 0.007 mM de Gusseme et al. (2011)
Stenotrophomonas sp. f1 Paracetamol 2.64 mM Zhang et al. (2013)
Pseudomonas sp. f2 Paracetamol 16.54 mM Zhang et al. (2013)
Pseudomonas sp. fg-2 Paracetamol 13.23 mM Zhang et al. (2013)
Penicillium sp. Paracetamol 0.66 mM Hart and Orr (1975)
Filamentous fungi Paracetamol 0.99 mM Huang et al. (2006)
Nocardia sp. NRRL 5646 Ibuprofen 4.85 mM Chen and Rosazza (1994)
Sphingomonas Ibu-2 Ibuprofen 2.42 mM Murdoch and Hay (2005)
Patulinobacter sp. I11 Ibuprofen 0.002 mM Almeida et al. (2013)
Bjerkandera sp. R1 Ibuprofen 0.0049–0.0097 mM Rodarte-Morales et al. (2011)
Bjerkandera adusta Ibuprofen 0.0049-0.0097 mM Rodarte-Morales et al. (2011)
Phanerochaete chrysosporium Ibuprofen 0.0049–0.0097 mM Rodarte-Morales et al. (2011)
Trametes versicolor Ibuprofen 0.097 mM Marco-Urrea et al. (2009)
Irpex lacteus Ibuprofen 0.097 mM Marco-Urrea et al. (2009)
Ganoderma lucidum Ibuprofen 0.097 mM Marco-Urrea et al. (2009)
Phanerochaete chrysosporium Ibuprofen 0.097 mM Marco-Urrea et al. (2009)
SA salicylic acid, ASA acetylsalicylic acid (aspirin), ND no data
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reducing the second oxygen atom towater. All salicylate
hydroxylases need NADH to remain active. The oxida-
tion of NADH is directly connected with FAD reduction
(Katagiri et al. 1965; Sze and Dagley 1984; Grund et al.
1992; Suzuki et al. 1996; Fuenmayor et al. 1998;
Balashova et al. 2001; Zhou et al. 2002; Jouanneau
et al. 2007).
Chakrabarty (1972) and Deveryshetty et al. (2007)
examined the ability of Pseudomonas putida R1 and
Alcaligenes sp. PPH, respectively, to degrade salicylate.
It was decomposed to catechol, the key intermediate,
and further to 2-hydroxymuconic semialdehyde as a
product of ring fission. Because of the significant activ-
ity of catechol 2,3-dioxygenase the authors concluded
that P. putida R1 was capable of meta cleavage. On the
other hand, decomposition of salicylate via catechol
may also run via ortho cleavage with cis,cis-muconic
acid as an aromatic ring cleavage product. Not only
bacteria, such as Amycolatopsis, Streptomyces, or Pseu-
domonas, but also fungi, like Fusarium, Rhodotorula,
Trichosporon, and Sclerotinia show that kind of cate-
chol ring fission (Shamsuzzaman and Barnsley 1974;
Anderson and Dagley 1980; Sze and Dagley 1984;
Grund et al. 1990; Fuenmayor et al. 1998; Civilini
et al. 1999; Ishiyama et al. 2004; Iwasaki et al. 2009;
Qi et al. 2012; Penn and Daniel 2013).
Salicylate degradation may also lead via hydroxyl-
ation to gentisate. For example, this pathway was re-
ported for Rhodococcus sp. B4 or Streptomyces sp.
WA46 strains (Grund et al. 1992; Ishiyama et al.
2004). Enzymes engaged in this pathway need for their
activity NADH, CoA and ATP as cofactors. Salicylate is
converted to gentisate via salicylyl-CoA and gentisyl-
CoA. In the first step, salicylyl-AMP ligase and proba-
bly salicylyl-CoA synthetase catalyze the formation of
the thioester bond between salicylate and CoA and
create salicylyl-CoA. The next step is the hydroxylation
by salicylyl-CoA 5-hydroxylase with the formation of
gentisyl-CoA. Hydrolysis to gentisate opens the way to
ring cleavage by gentisate 1,2-dioxygenase to
maleylpyruvate which leads to central metabolism.
Civilini et al. (1999) showed the ability of Pseudomonas
aeruginosa 2NR to convert salicylate into both interme-
diates, calechol, and gentisate.
Iwasaki et al. (2009) described a different model of
decomposition of salicylate via catechol by yeast
Trichosporon moniliiforme WU-0401. In their study, a
non-oxidative way with phenol as an intermediate of
salicylate degradation to catechol was presented.
Salicylate was immediately transformed to phenol with,
simultaneously, decarboxylation, but without hydroxyl-
ation. Before that, phenol was hydroxylated to catechol
and further cleaved in the ortho position.
Most bacteria degrade salicylate via oxidative decar-
boxylation to catechol or via hydroxylation to gentisate.
Pseudaminobacter salicylatoxidans B12 is capable of
direct ring cleavage using NADH-independent salicy-
late 1,2-dioxygenase forming 2-oxohepta-3,5-
dienedioic acid as an aliphatic product (Hintner et al.
2001).
5 Microbial Degradation and Transformation
of Paracetamol
Paracetamol (acetaminophen) is an analgesic and anti-
pyretic drug, and is one of the most popular over-the-
counter drugs (Chandrasekharan et al. 2002). Acetamin-
ophen is in most cases metabolized in the liver via three
metabolic pathways. Most of this drug is secreted as
conjugates with glucuronic acid (60%) or sulfate (30%)
(Herd et al. 1991). A small amount of the medicine
(8 %) may be dehydrogenated by cytochrome P450 to
a toxic derivative N-acetyl-p-benzoquinone imine
(Bock et al. 1987; Herd et al. 1991; Bessems and
Vermeulen 2001). Nevertheless, knowledge about the
further fate of acetaminophen in the environment is still
limited. Hart and Orr (1975) obtained Penicillium sp.
able to transform paracetamol to 4-aminophenol and
acetate, probably with the use of aryl acylamidase. 4-
Aminophenol is a dead-end metabolite (Fig. 1). Ivshina
et al. (2006) reported the ability of Rhodococcus strains
to degrade paracetamol with three detectable metabo-
lites: 4-aminophenol, catechol, and hydroquinone. 4-
Aminophenol may undergo oxidative deamination to
hydroquinone (de Gusseme et al. 2011; Wei et al.
2011; Wu et al. 2012; Zhang et al. 2013). Further
degradation of 1,4-hydroxybenzene could proceed in
two ways. Hydroquinone may be directly cleaved by
hydroquinone 1,2-dioxygenase with 4-hydroxymuconic
semialdehyde as an aliphatic product (Jain et al. 1994;
Rieble et al. 1994; Daubaras et al. 1996). This pathway
was also suggested by de Gusseme et al. (2011), which
observed degradation of hydroquinone by Delftia
tsuruhatensis and Pseudomonas aeruginosa. The sec-
ond way was described by Takenaka et al. (2003). These
authors showed that Burkholderia sp. AK-4 converted
4-aminophenol to 1,4-hydroxybenzene and further to
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1,2,4-trihydroxybenzene. Then 1,2,4-trihydroxybenzene
was cleaved by hydroxyhydroquinone 1,2-dioxygenase
to maleylacetic acid, which is introduced to the basic
metabolism (Mason and Cammack 1992; Chauhan
et al. 2000; Miyauchi et al. 1999; Moonen et al. 2008;
Kolvenbach et al. 2011) (Fig. 1). Zhang et al. (2013)
described the conversion of acetaminophen to hydroqui-
none, which was next transformed to an aliphatic product
hexa-3-enedioic acid. Unfortunately, the authors did not
determine the enzyme engaged in ring cleavage. How-
ever, it seems that hexa-3-enedioic acid was a product of
aromatic ring fission or, if not, it that means some inter-
mediate metabolites between aromatic and aliphatic com-
pounds were passed over. Hexa-3-enedioic acid is similar
to muconic acid—a product of ortho ring cleavage of
catechol, but the authors did not find catechol in the
studied samples. Based on reported intermediates a pri-
mary pathway of acetaminophen degradation could be
proposed. The mechanism may be based on cutting off
two carbon atoms in the form of formic acid (Fig. 1)
(Zhang et al. 2013).
Furthermore, Huang et al. (2006) described the for-
mation of glucoside conjugates with paracetamol by soil
filamentous fungi via O- and N-linkages. This is a
similar way to the human detoxication routes of xeno-
biotics in phase II of detoxication (Halling-Sorensen
et al. 1998).
In 2014, Li et al. described degradation pathway
of paracetamol in soil microorganisms. It was shown
that in the first step, aromatic ring of paracetamol is
hydroxylated to 3-hydroxyacetaminophen, oxygen-
ated to N-acetyl-p-benzoquinone imine, or methyl-
ated to p-acetanisidide. It is suggested that cyto-
chrome P-450 may be engaged in these processes.
N-acetyl-p-benzoquinone imine is then metabolized
to 1,4-benzoquinone which is more stable and
critical toxic metabolite. p-Acetanisidide is trans-
formed to 4-methoxyphenol and in the next step to
the 1,4-dimethoxybenzene. The presence of 2-
hexenoic acid in the soil extract suggests the
cleavage of the aromatic ring of paracetamol (Li
et al. 2014).
Fig. 1 Biotransformation of paracetamol (Hart and Orr 1975; Takenaka et al. 2003; Kolvenbach et al. 2011; Wu et al. 2012; Zhang et al.
2013; Guzik et al. 2014; Li et al. 2014)
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6 Biodegradation/Biotransformation of Ibuprofen
Ibuprofen (2-(4-(2-methylpropyl)phenyl)propanoic ac-
id) is one of the most popular and commonly used
non-steroidal anti-inflammatory drugs. This makes it
the third most popular drug in the world. Ibuprofen is
also one of the dominating medicines present in sewage
because of its relatively high therapeutic dose (600–
1200 mg per day), and significant levels are excreted
from the human body (even 70–80 %). This drug may
be secreted as an unchanged molecule or as an un-
changed molecule in conjugation with glucuronide
(product of the second phase of detoxication that may
be hydrolyzed in the environment) or as a few metabo-
lites: hydroxyibuprofen (two isomers), carboxyibuprofen,
and carboxyhydratropic acid (Halling-Sorensen et al.
1998; Buser et al. 1999; Zwiener et al. 2002). Nonetheless,
little is still known about the environmental metabolism of
ibuprofen, whose concentration in the environment ranges
from nanograms per liter to micrograms per liter (Calamari
et al. 2003; Bendz et al. 2005; Tauxe-Wuersch et al. 2005;
Nakada et al. 2006; Roberts and Thomas 2006; Gómez
et al. 2007; Lin et al. 2009; Pailler et al. 2009).
Many reports describe only the initial steps of ibu-
profen transformation. Rodarte-Morales et al. (2011)
used three species of ligninolytic fungi: Bjerkandera
sp. R1, Bjerkandera adusta, and Phanerochaete
chrysosporium to check their ability to degrade pharma-
ceuticals, including ibuprofen (Table 2). They reported a
rapid decrease of ibuprofen in growth medium,
explaining that fact by degradation of the drug. Howev-
er, these authors did not search for intermediates
occurring in the degradation process, and they noted
only the loss of the parent compound. It may be sug-
gested that ibuprofen was not completely mineralized.
Trametes versicolor, Irpex lacteus, Ganoderma
lucidum, and P. chrysosporium are fungi capable of
degrading ibuprofen (Marco-Urrea et al. 2009). All of
them, excluding P. chrysosporium, degraded 10 mg/L
ibuprofen to non-detectable levels. P. chrysosporium
showed the lowest degradation level, between 70 and
88 %. Simultaneously, it should be noted that the au-
thors tested the in vitro activity of laccase (also with
laccase mediators) and manganese peroxidase. More-
over, they used inhibitors of the cytochrome P-450
complex to analyze the participation of these enzymes
in ibuprofen degradation. In all cases, the researchers
did not observe the contribution of the examined en-
zymes in the metabolism of ibuprofen. It may be sug-
gested that the metabolism of ibuprofen could run
through another pathway. The major metabolites which
were found were hydroxylated in the isopropyl chain
from ibuprofen—1- and 2-hydroxyibuprofen after the
f i r s t h o u r s o f t h e e x p e r imen t , a n d 1 , 2 -
dihydroxyibuprofen as a final metabolite after 7 days
of cultivation (Fig. 2). Hydroxylated and carboxylated
derivatives are frequent in the microbial metabolism
(Zwiener et al. 2002; Quintana et al. 2005). It is note-
worthy that ibuprofen derivatives are more toxic than
the parent compound and may accumulate in the envi-
ronment (Marco-Urrea et al. 2009). Despite low con-
centrations of these compounds in the ecosystem, they
may be hazardous. However, the long-term effects of the
organism exposure to this drug cannot be defined (Perry
Fig. 2 Microbiological transformation of ibuprofen (Chen and Rosazza 1994; Murdoch and Hay 2005; Quintana et al. 2005; Guzik et al.
2014)
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and Zylstra 2007). On the basis of European Union law,
Cleuvers (2004) did not classify ibuprofen as toxic to
aquatic organisms. However, a study with Daphnia
magna and green algae showed that ibuprofen may be
a toxic factor, especially in the presence of other drugs.
This study informs about the effect of high-dose toxicity
in short time exposure. In the environment, pharmaceu-
ticals are not in high concentrations, so greater emphasis
should be put on studies on the chronic toxicity of drugs
(Cleuvers 2004).
During the degradation of ibuprofen by the lignolytic
bacterium Nocardia sp. NRRL 5646, two metabolites,
ibuprofenol and ibuprofenol acetate, were observed
(Fig. 2). These products underwent further mineraliza-
tion (Chen and Rosazza 1994).
Murdoch and Hay (2005, 2013) characterized one of
the most completed ibuprofen degradation pathways in
Sphingomonas Ibu-2 bacteria, capable of using ibupro-
fen as a source of carbon and energy. Based on genetic
analyses, they proposed five-gene cluster (ipfABDEF),
coding enzymes putatively involved in ibuprofen catab-
olism. Two of these genes (ipfA, ipfB) were very similar
to genes coding two subunits of dioxygenases; the third
gene was identified as a gene coding enzyme for the
removal/addition of acyl groups—acyl-CoA synthetase
(IpfD); the fourth one (ipfF) was described as a coen-
zyme A ligase gene; and for the gene ipfE, no function
was found. Two additional genes ipfH and ipfI encode
ferredoxin reductase and ferredoxin components of an
aromatic dioxygenase system, respectively (Murdoch
and Hay 2013). As the first step in the decomposition
of ibuprofen by strain Ibu-2, thioesterification with co-
enzyme A with the participation of coenzyme A ligase
was suggested. Removal of the propionic acid chain and
dioxygenation reaction led to isobutylocatechol forma-
tion. This compound undergoes oxygenolytic cleavage
(Murdoch and Hay 2005; Murdoch and Hay 2013)
(Fig. 2). Ibuprofen biotransformation by Variovorax
Ibu-1 occurs with trihydroxyibuprofen as a metabolite.
This compound may be a dead-end metabolite or is
substrate to the meta-ring fission reaction (Murdoch
and Hay 2015).
Patulinobacter sp. I11 did not grow with ibuprofen as
the only source of carbon and energy. However, degrada-
tion of ibuprofen was observed in the presence of yeast
extract and tryptone. This suggests that ibuprofen could
not induce the expression of enzymes responsible for its
decomposition. In the bacterial genome, homologous
genes were found coding enzymes potentially involved
in ibuprofen decomposition, such as acyl-CoA synthetase,
a protein containing a Rieske-like (2Fe-2S) iron-sulfur
cluster (dioxygenase-like protein), and enoyl-CoA
hydratase/isomerase (Almeida et al. 2013).
7 Conclusion
The occurrence of micropollutants in the environment,
such as non-steroidal anti-inflammatory drugs, is a rel-
atively new problem. The presence of these drugs in the
environment poses a risk of long-term exposure, causing
chronic toxic effects for organisms. Although the
salicylic acid pathway is very well described, little is
known about the biotransformation/biodegradation of
other non-steroidal anti-inflammatory drugs such as
ibuprofen or paracetamol. Paracetamol degradation
pathways lead through hydroquinone as a key interme-
diate, whereas ibuprofen is metabolized by hydroxyl-
ation or activation with CoA. However, sometimes bio-
transformation of monocyclic NSAIDs leads to the ac-
cumulation of intermediates more toxic than the parent
compounds. An understanding the drug mineralization
processes is key to creating commercially available
solutions for this increasing problem.
Compliance with Ethical Standards
Funding This work was financed by the National Science Cen-
tre (Poland), granted on the basis of decision DEC-2013/09/B/
NZ9/00244.
Conflict of Interest The authors declare that they have no
conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestrict-
ed use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if
changes were made.
References
Almeida, B., Kjeldal, H., Lolas, I., Knudsen, A. D., Carvalho, G.,
Nielsen, K. L., Barreto Crespo, M. T., Stensballe, A., &
Nielsen, J. L. (2013). Quantitative proteomic analysis of
ibuprofen-degrading Patulibacter sp. strain I11.
Biodegradation, 24, 615–630.
Water Air Soil Pollut (2015) 226: 355 Page 9 of 13 355
Anderson, J. J., & Dagley, S. (1980). Catabolism of aro-
matic acids in Trichosporon cutaneum. Journal of
Bacteriology, 141(2), 534–543.
Balashova, N. V., Stolz, A., Knackmuss, H. J., Kosheleva, I. A.,
Naumov, A. V., & Boronin, A. M. (2001). Purification and
characterization of a salicylate hydroxylase involved in 1-
hydroxy-2-naphthoic acid hydroxylation from the naphtha-
lene and phenanthrene-degrading bacterial strain
Pseudomonas putida BS202-P1. Biodegradation, 12, 179–
188.
Bender, M., & MacCrehan, W. A. (2006). Transformation of
acetaminophen by chlorination produces the toxicants 1,4-
benzoquinone and N-acetyl-p-benzoquinone imine.
Environmental Science and Technology, 40, 516–522.
Bender, R. P., Lindsey, R. H., Burden, D. A., & Osheroff, N.
(2004). N-Acetyl-p-benzoquinone imine, the toxic metabo-
lite of acetaminophen, is a topoisomerase II poison.
Biochemistry, 43, 3731–3739.
Bendz, D., Paxéus, N. A., Ginn, T. R., & Loge, F. J. (2005).
Occurrence and fate of pharmaceutically active compounds
in the environment, a case study: Höje river in Sweden.
Journal of Hazardous Materials, 122, 195–204.
Bertini, I., Cremonini, M. A., Ferretti, S., Lozzi, I., Luchinat, C., &
Viezzoli, M. S. (1996). Arene hydroxylases: metalloenzymes
catalysing dioxygenation of aromatic compounds.
Coordination Chemistry Review, 151, 145–160.
Bessems, J. G. M., & Vermeulen, N. P. E. (2001). Paracetamol
(acetaminophen)-induced toxicity: molecular and biochemi-
cal mechanisms, analogues and protective approaches.
Critical Review in Toxicology, 31(1), 55–138.
Bock, K. W., Wiltfang, J., Blume, R., Ullrich, D., & Bircher, J.
(1987). Paracetamol as a test drug to determine glucuronide
formation in man. Effects of inducers and of smoking.
European Journal of Clinical Pharmacology, 31, 677–683.
Brausch, J. M., Connors, K. A., Brooks, B. W., & Rand, G. M.
(2012). Human pharmaceuticals in the aquatic environment:
a review of recent toxicological studies and consideration for
toxicity testing. Reviews of Environmental Contamination
and Toxicology, 218, 1–99.
Buser, H. R., Poiger, T., & Muller, M. D. (1999). Occurrence and
environmental behavior of the chiral pharmaceutical drug
ibuprofen in surface waters and in wastewater.
Environmental Science and Technology, 33, 2529–2535.
Calamari, D., Zuccato, E., Castiglioni, S., Bagnati, R., & Fanelli,
R. (2003). Strategic survey of therapeutic drugs in the Rivers
Po and Lambro in Northern Italy. Environmental Science and
Technology, 37, 1241–1248.
Calleja, M. C., Personne, G., & Geladi, P. (1994). Comparative
acute toxicity of the first 50 multicentre evaluation of in vitro
cytotoxicity chemicals to aquatic non vertebrates. Archives of
Environmental Contamination and Toxicology, 26, 69–78.
Carlsson, C., Johansson, A. K., Alvan, G., Bergman, K., &Kühler,
T. (2006). Are pharmaceuticals potent environmental pollut-
ants? Part I: Environmental risk assessments of selected
active pharmaceutical ingredients. Science of the Total
Environment, 364, 67–87.
Chakrabarty, A. M. (1972). Genetic basis of the biodegradation of
salicylate in Pseudomonas. Journal of Bacteriology, 112(2),
815–822.
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K.,
Tomsik, J., Elton, T. S., & Simmons, D. L. (2002). COX-3, a
cyclooxygenase-1 variant inhibited by acetaminophen and
other analgesic/antipyretic drugs: cloning, structure, and ex-
pression. Proceedings of the National Academy of Sciences,
99(21), 13926–13931.
Chauhan, A., Samanta, S. K., & Jain, R. K. (2000). Degradation of
4-nitrocatechol by Burkholderia cepacia: a plasmid-encoded
novel pathway. Journal of AppliedMicrobiology, 88(5), 764–
772.
Chen, Y., & Rosazza, J. P. N. (1994). Microbial transformation of
ibuprofen by aNocardia species. Applied and Environmental
Microbiology, 60, 1292–1296.
Civilini, M., de Bertoldi, M., & Tell, G. (1999). Molecular char-
acterization of Pseudomonas aeruginosa 2NR degrading
naphthalene. Letters in Applied Microbiology, 29, 181–186.
Cleuvers, M. (2004). Mixture toxicity of the anti-inflammatory
drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic
acid. Ecotoxicology and Environmental Safety, 59, 309–315.
Daubaras, D. L., Saido, K., & Chakrabarty, A. M. (1996).
Purification of hydroxyquinol 1,2-dioxygenase and
maleylacetate reductase: the lower pathway of 2,4,5-
trichlorophenoxyacetic acid metabolism by Burkholderia
cepac ia AC1100. Appl ied and Envi ronmenta l
Microbiology, 62(11), 4276–4279.
de Gaetano, G., Cerletti, C., Dejana, E., & Latini, R. (1985).
Pharmacology of platelet inhibition in humans: implications
of the salicylate–aspirin interaction. Circulation, 72(6),
1185–1193.
de Gusseme, B., Vanhaecke, L., Verstraete, W., & Boon, N.
(2011). Degradation of acetaminophen by Delftia
tsuruhatensis and Pseudomonas aeruginosa in a membrane
bioreactor. Water Research, 45, 1829–1837.
de Lange, H. J., Noordoven, W., Murk, A. J., Lurling, M., &
Peeters, E. T. H. M. (2006). Behavioural responses of
Gammarus pulex (Crustacea, Amphipoda) to low concentra-
tions of pharmaceuticals. Aquatic Toxicology, 78, 209–216.
Dębska, J., Kot-Wasik, A., & Namiesnik, J. (2005). Determination
of nonsteroidal anti-inflammatory drugs in water samples
using liquid chromatography coupled with diode–array de-
tector and mass spectrometry. Journal of Separation Science,
28, 2419–2426.
Deveryshetty, J., Suvekbala, V., Varadamshetty, G., & Phale, P. S.
(2007). Metabolismof 2-, 3- and 4-hydroxybenzoates by soil
isolates Alcaligenes sp. strain PPH and Pseudomonas sp.
strain PPD. FEMS Microbiology Letters, 268, 59–66.
Fuenmayor, S. L., Wild, M., Boyes, A. L., & Williams, P. A.
(1998). A gene cluster encoding steps in conversion of naph-
thalene to gentisate in Pseudomonas sp. strain U2. Journal of
Bacteriology, 180(9), 2522–2530.
Gómez, M. J., Martínez Bueno, M. J., Lacorte, S., Fernández-
Alba, A. R., & Agüera, A. (2007). Pilot survey monitoring
pharmaceuticals and related compounds in a sewage treat-
ment plant located on the Mediterranean coast.
Chemosphere, 66, 993–1002.
Grant, D. J. W. (1971). Degradation of acetylsalicylic acid by a
strain of Acinetobacter lwoffii. Journal of Applied
Bacteriology, 34, 689–698.
Grund, E., Denecke, B., & Eichenlaub, R. (1992).
Naphthalene degradation via salicylate and gentisate
by Rhodococcus sp . s t r a in B4. Appl ied and
Environmental Microbiology, 58(6), 1874–1877.
355 Page 10 of 13 Water Air Soil Pollut (2015) 226: 355
Grund, E., Knorr, C., & Eichenlaub, R. (1990). Catabolism of
benzoate and monohydroxyla ted benzoa tes by
Amycolatopsis and Streptomyces spp. Applied and
Environmental Microbiology, 56(5), 1459–1464.
Guzik, U., Hupert-Kocurek, K., Mazur, A., & Wojcieszyńska, D.
(2013a). Biotransformacja wybranych niesteroidowych
leków przeciwzapalnych w środowisku. Bromatologia i
Chemia Toksykologiczna, 1, 105–112 (in Polish).
Guzik, U., Hupert-Kocurek, K., & Wojcieszyńska, D. (2013b).
Intradiol dioxygenases—the key enzymes in xenobiotics
degradation. In: Chamy, R., & Rosenkranz, F. (Ed.),
Biodegradation of Hazardous and Special Products (pp.
129–153). Rijeka
Guzik, U., Hupert-Kourek, K., & Wojcieszyńska, D. (2014).
Microbial degradation non-steroidal anti-inflammatory
drugs. Postepy Mikrobiologii, 53, 61–69 (in Polish).
Halling-Sorensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F.,
Holten Lützhof, H. C., & Jorgensen, S. E. (1998).
Occurrence, fate, and effects of pharmaceutical substances
in the environment—a review. Chemosphere, 36, 357–393.
Han, S., Choi, K., Kim, J., Ji, K., Kim, S., Aho, B., Yun, J., Choi,
K., Khim, J. S., Zhang, X., & Giesy, J. P. (2010). Endocrine
disruption and consequences of chronic exposure to ibupro-
fen in Japanese medaka Oryzias latipes and freshwater cla-
docerans Daphnia magna and Moina macrocopa. Aquatic
Toxicology, 98, 256–264.
Haribabu, B., Kamath, A. V., & Vaidyanathan, C. S. (1984).
Degradation of substituted benzoic acids by a Micrococcus
species. FEMS Microbiology Letters, 21(2), 197–200.
Hart, A., & Orr, D. L. J. (1975). The degradation of paracetamol
(4-hydroxyacetanilide) and other substituted acetanilides by a
Penicillium species.Antonie van Leeuwenhoek, 41, 239–247.
Heberer, T. (2002). Occurrence, fate, and removal of pharmaceu-
ticals residues in the aquatic environment: a review of recent
research data. Toxicology Letters, 131, 5–17.
Henschel, K. P., Wenzel, A., Diederich, M., & Fliedner, A. (1997).
Environmental hazard assessment of pharmaceuticals.
Regulatory Toxicology and Pharmacology, 25, 220–225.
Herd, B., Wynne, H., Wright, P., James, O., & Woodhouse, K.
(1991). The effect of age on glucuronidation and sulphation
of paracetamol by human liver fractions. British Journal of
Clinical Pharmacology, 32, 768–770.
Hinson, A. H., Roberts, D.W., & James, L. P. (2010). Mechanisms
of acetaminophen-induced liver necrosis. Handbook of
Experimental Pharmacology, 196, 369–405.
Hintner, J. P., Lechner, C., Riegert, U., Kuhm, A. E., Storm, T.,
Reemtsma, T., & Stolz, A. (2001). Direct ring fission of
salicylate by a salicylate 1,2-dioxygenase activity from
Pseudaminobacter sal icylatoxidans. Journal of
Bacteriology, 183(23), 6936–6942.
Huang, H. H., Lin, L. H., Zhang, P., Qi, X. L., & Zhong, D. F.
(2006). Formation of glucoside conjugate of acetaminophen
by fungi separated from soil. European Journal of Drug
Metabolism and Pharmacokinetics, 31(2), 103–108.
Ingelman-Sundberg, M., Kaur, H., Terelius, Y., Persson, J. O., &
Halliwell, B. (1991). Hydroxylation of salicylate by micro-
somal fractions and cytochrome P-450.Biochemical Journal,
276, 753–757.
Ishiyama, D., Vujaklija, D., & Davies, J. (2004). Novel
pathway of salicylate degradation by Streptomyces sp.
strain WA46. Applied and Environmental Microbiology,
70(3), 1297–1306.
Ivshina, I. B., Rychkova, M. I., Vikhareva, E. V., Chekryshkina, L.
A., &Mishenina, I. I. (2006). Catalysis of the biodegradation
of unusable medicines by alkanotrophic Rhodococci. Applied
Biochemistry and Microbiology, 42, 392–395.
Iwasaki, Y., Gunji, H., Kino, K., Hattori, T., Ishii, Y., & Kirimura,
K. (2009). Novel metabolic pathway for salicylate biodegra-
dation via phenol in yeast Trichosporon moniliiforme.
Biodegradation, 21, 557–564.
Jain, R. K., Dreisbach, J. H., & Spain, J. C. (1994). Biodegradation
of p-nitrophenol via 1-, 2-, 4-benzenetriol by an Arthrobacter
sp. Applied and Environmental Microbiology, 60(8), 3030–
3032.
Jouanneau, Y., Micoud, J., & Meyer, C. (2007). Purification and
characterization of a from Sphingomonas sp. strain CHY-1
three-component salicylate 1-hydroxylase. Applied and
Environmental Microbiology, 73(23), 7515–7521.
Katagiri, M., Maeno, H., Yamamoto, S., Hayaishi, O., Kitao, T., &
Oae, S. (1965). Salicylate hydroxylase, a monooxygenase
requiring flavin adenine dinucleotide II. The mechanism of
salicylate hydroxylation to catechol. The Journal of
Biological Chemistry, 240, 3414–3417.
Khan, S. J., & Ongerth, J. E. (2002). Estimation of pharmaceutical
residues in primary and secondary sewage sludge based on
quantities of use and fugacity modeling. Water Science and
Technology, 46, 105–113.
Kim, J. W., Ishibashi, H., Yamauchi, R., Ichikawa, N., Takao, Y.,
Hirano, M., Koga, M., & Arizono, K. (2009). Acute toxicity
of pharmaceutical and personal care products on freshwater
crustacean Thamnocephalus platyurus and fish Oryzias
latipes. Journal of Toxicological Sciences, 342, 227–232.
Kolpin, D. W., Skopiec, M., Meyer, M. T., Furlong, E. T., &
Zaugg, S. D. (2004). Urban contribution of pharmaceuticals
and other organic wastewater contaminants to streams during
differing flow conditions. Science of the Total Environment,
328, 119–130.
Kolvenbach, B. A., Lenz, M., Benndorf, D., Rapp, E., Fousek, J.,
Vlcek, C., Schäffer, A., Gabriel, F. L. P., Kohler, H. P. E., &
Corvini, P. F. X. (2011). Purification and characterization of
hydroquinone dioxygenase from Sphingomonas sp. strain
TTNP3. AMB Express, 1(8), 2–11.
Kühn, R., Pattard, M., Pernak, K. D., &Winter, A. (1989). Results
of the harmful effects of selected water pollutants (anilines,
phenols, aliphatic compounds) to Daphnia magna. Water
Research, 23(4), 495–499.
Kuspis, D. A., &Krenzelok, E. P. (1996).What happens to expired
medications? A survey of community medication disposal.
Veterinary and Human Toxicology, 38(1), 48–49.
Kuswandi, K., & Roberts, C. F. (1992). Genetic control of the
protocatechuic acid pathway inAspergillus nidulans. Journal
of General Microbiology, 138, 817–823.
Lanfranconi, M. P., Christie-Oleza, J. A., Martin-Cardona, C.,
Suárez-Suárez, L. Y., Lalucat, J., Nogales, B., & Bosch, R.
(2009). Physiological role of NahW, the additional salicylate
hydroxylase found in Pseudomonas stutzeri AN10. FEMS
Microbiology Letters, 300, 265–272.
Lee, H. B., Peart, T. E., & Svoboda, M. L. (2005). Determination
of endocrine-disrupting phenols, acidic pharmaceuticals, and
personal-care products in sewage by solid-phase extraction
Water Air Soil Pollut (2015) 226: 355 Page 11 of 13 355
and gas chromatography–mass spectrometry. Journal of
Chromatography. A, 1094, 122–129.
Li, J., Ye, Q., & Gan, J. (2014). Degradation and transformation
products of acetaminophen in soil. Water Research, 49, 44–
52.
Lilius, H., Isomaa, B., & Holmstrom, T. (1994). A comparison of
the toxicity of 50 reference chemicals to freshly isolated
rainbow trout hepatocytes and Daphnia magna. Aquatic
Toxicology, 30, 47–60.
Lin, A. Y. C., Yu, T. H., & Lateef, S. K. (2009). Removal of
pharmaceuticals in secondary wastewater treatment process-
es in Taiwan. Journal of Hazardous Materials, 167, 1163–
1169.
Marco-Urrea, E., Pérez-Trujillo, M., Vicent, T., & Caminal, G.
(2009). Ability of white-rot fungi to remove selected phar-
maceuticals and identification of degradation products of
ibuprofen by Trametes versicolor. Chemosphere, 74, 765–
772.
Mason, J. R., & Cammack, R. (1992). The electron transport
proteins oh hydroxylating bacterial dioxygenases. Annual
Review of Microbiology, 46, 277–305.
Metcalfe, C., Miao, X. S., Hua, W., Letcher, R., & Servos, M.
(2004). Pharmaceuticals in the Canadian environment. In K.
Kümmerer (Ed.), Pharmaceuticals in the environment.
Sources, fate, effects and risks (pp. 67–90). Berlin:
Springer-Verlag.
Middelhoven,W. J. (1993). Catabolism of benzene compounds by
ascomycetous and basidiomycetous yeasts and yeast-like
fungi. Antonie van Leeuwenhoek, 63, 125–144.
Miyauchi, K., Adachi, Y., Nagata, Y., & Takagi, M. (1999).
Cloning and sequencing of a novel meta-cleavage
dioxygenase gene whose product is involved in degradation
of gamma-hexachlorocyclohexane in Sphingomonas
paucimobilis. Journal of Bacteriology, 181(21), 6712–6719.
Moonen, M. J. H., Synowsky, S. A., van den Berg, W. A. M.,
Westphal, A. H., Heck, A. J. R., van den Heuvel, R. H. H.,
Fraaije, M.W., & van Berkel,W. J. H. (2008). Hydroquinone
dioxygenase from Pseudomonas fluorescens ACB: a novel
member of the family of nonheme-iron(II)-dependent
dioxygenases. Journal of Bacteriology, 190(15), 5199–5209.
Murdoch, R. W., & Hay, A. G. (2005). Formation of catechols via
removal of acid side chains from ibuprofen and related aro-
matic acids. Applied and Environmental Microbiology,
71(10), 6121–6125.
Murdoch, R. W., & Hay, A. G. (2013). Genetic and chemical
characterization of ibuprofen degradation by Sphingomonas
Ibu-2. Microbiology, 159, 621–632.
Murdoch, R. W., & Hay, A. G. (2015). The biotransformation of
ibuprofen to trihydroxyibuprofen in activated sludge and by
Variovorax Ibu-1. Biodegradation, 26, 105–113.
Musson, S. E., & Townsend, T. G. (2009). Pharmaceutical com-
pound content of municipal solid waste. Journal of
Hazardous Materials, 162, 730–735.
Nakada, N., Tanishima, T., Shinohara, H., Kiri, K., & Takada, H.
(2006). Pharmaceutical chemicals and endocrine disrupters
in municipal wastewater in Tokyo and their removal during
activated sludge treatment.Water Research, 40, 3297–3303.
Newton, J. F., Kuo, C. H., Gemborys, M. W., Mudge, G. H., &
Hook, J. B. (1982). Nephrotoxicity of p-aminophenol, a
metabolite of acetaminophen, in the Fischer 344 rat.
Toxicolology and Applied Pharmacology, 65, 336–344.
Pailler, J. Y., Pfister, K. L., Hoffmann, L., & Guignard, C. (2009).
Solid phase extraction coupled to liquid chromatography–
tandem mass spectrometry analysis of sulfonamides, tetracy-
clines, analgesics and hormones in surface water and waste-
water in Luxembourg. Science of the Total Environment, 40,
4736–4743.
Paterson, J. R., Baxter, G., Dreyer, J. S., Halket, J.M., Flynn, R., &
Lawrence, J. R. (2008). Salicylic acid sans aspirin in animals
and man: persistence in fasting and biosynthesis from
benzoic acid. Journal of Agricultural and Food Chemistry,
56, 11648–11652.
Penn, C. D., & Daniel, S. L. (2013). Salicylate degradation by the
fungal plant pathogen Sclerotinia sclerotiorum. Current
Microbiology, 67(2), 218–225.
Perry, L. L., & Zylstra, J. (2007). Cloning of a gene cluster
involved in the catabolism of p-nitrophenol by Arthrobacter
sp. strain JS443 and characterization of the p-nitrophenol
monooxygenase. Journal of Bacteriology, 189(21), 7563–
7572.
Pomati, F., Netting, A. G., Calamari, D., & Neilan, B. A. (2004).
Effects of erythromycin, tetracyclin and ibuprofen on the
growth of Synechocystis sp. and Lemna minor. Aquatic
Toxicology, 67, 387–396.
Pounds, N., Maclean, S., Webley, M., Pascoe, D., & Hutchinson,
T. (2008). Acute and chronic effects of ibuprofen in the
mollusc Planorbis carinatus (Gastropoda: Planorbidae).
Ecotoxicology and Environmental Safety, 70, 47–52.
Qi, P. F., Johnston, A., Balcerzak, M., Rocheleau, H., Harris, L. J.,
Long, X. Y., Wei, Y. M., Zheng, Y. L., & Ouellet, T. (2012).
Effect of salicylic acid on Fusarium graminearum, the major
casual agent of fusarium head blight in wheat. Fungal
Biology, 116, 413–426.
Quinn, B., Gagne, F., & Blaise, C. (2008). An investigation into
the acute and chronic toxicity of eleven pharmaceuticals (and
their solvents) found in wastewater effluent on the cnidarians,
Hydra attenuate. Science of the Total Environment, 389,
306–314.
Quintana, J. B., Weiss, S., & Reemtsma, T. (2005). Pathways and
metabolites of microbial degradation of selected acidic phar-
maceutical and their occurrence in municipal wastewater
treated by a membrane bioreactor. Water Research, 39,
2654–2664.
Rieble, S., Joshi, D. K., & Gold, M. H. (1994). Purification and
characterization of a 1-, 2-, 4-trihydroxybenzene 1,2-
dioxygenase from the basidiomycete Phanerochaete
chrysosporium. Journal of Bacteriology, 176(16), 4838–
4844.
Roberts, P. H., & Thomas, K. V. (2006). The occurrence of
selected pharmaceuticals in wastewater effluent and surface
waters of the lower Tyne catchment. Science of the Total
Environment, 356, 143–153.
Rodarte-Morales, A. I., Feijoo, G., Moreira, M. T., & Lema, J. M.
(2011). Degradation of selected pharmaceutical and personal
care products (PPCPs) by white-rot fungi. World Journal of
Microbiology and Biotechnology, 27, 1839–1849.
Rzepa, J. (2009). Oznaczanie leków i pestycydów w wodach
powierzchniowych. In B. K. Głoda (Ed.), Postępy
Chromatografii (pp. 67–77). Siedlce: Wydawnictwo
Akademii Podlaskiej (in Polish).
Salgado, R., Noronha, J. P., Oehmen, A., Carvalho, G., & Reis, M.
A. M. (2010). Analysis of 65 pharmaceuticals and personal
355 Page 12 of 13 Water Air Soil Pollut (2015) 226: 355
care products in 5 wastewater treatment plants in Portugal
using a simplified analytical methodology. Water Science
and Technology, 6212, 2862–2871.
Shamsuzzaman, K., & Barnsley, E. A. (1974). The regulation of
naphthalene oxygenase in Pseudomonads. Biochemical and
Biophysical Research Communications, 60, 582–589.
Silva, T. R., Valdman, E., Valdman, B., & Leite, S. G. F. (2007).
Salicylic acid degradation from aqueous solutions using
Pseudomonas fluorescens HK44: parameters studies and ap-
plication tools. Brazilian Journal of Microbiology, 38, 39–
44.
Song, H., & Chen, T. S. (2001). p-Aminophenol-induced liver
toxicity: tentative evidence of a role for acetaminophen.
Journal of Biochemical and Molecular Toxicology, 15, 34–
40.
Sosnowska, K., Styszko-Grochowiak, K., & Gołaś, J. (2009). Leki
w środowisku – źródła, przemiany, zagrożenia. IV
Krakowska Konferencja Młodych Uczonych (pp. 395–404)
(in Polish).
Suzuki, K., Mizuguchi, M., Ohnishi, K., & Itagaki, E. (1996).
Structure of chromosomal DNA coding for Pseudomonas
putida S-1 salicylate hydroxylase. Biochimica et Biophysica
Acta, 1275, 154–156.
Sze, I. S., &Dagley, S. (1984). Properties of salicylate hydroxylase
and hydroxyquinol 1,2-dioxygenase purified from
Trichosporon cutaneum. Journal of Bacteriology, 159(1),
353–359.
Takenaka, S., Okugawa, S., Kadowaki, M., Murakami, S., &
Aoki, K. (2003). Metabolic pathway of 4-aminophenol in
Burkholderia sp. strain AK-5 differs from that of aniline and
aniline with C-4 substituents. Applied and Environmental
Microbiology, 69(9), 5410–5413.
Tauxe-Wuersch, A., de Alencastro, L. F., Grandjean, D., &
Tarradellas, J. (2005). Occurrence of several acidic drugs in
sewage treatment plants in Switzerland and risk assessment.
Water Research, 39, 1761–1772.
Ternes, T. A. (1998). Occurrence of drugs in German sewage
treatment plants and rivers.Water Research, 32, 3245–3260.
Tixier, C., Singer, H. P., Oellers, S., & Müller, S. R. (2003).
Occurrence and fate of carbamazepan, clofibric acid,
diclofenac, ibuprofen, ketoprofen and naproxen in surface
water. Environmental Science and Technology, 37, 1061–
1068.
Togola, A., & Budzinski, H. (2008). Multi-residue analysis of
pharmaceutical compounds in aqueous samples. Journal of
Chromatography A, 1177, 150–158.
Tsikas, D., Trettin, A., Zorner, A. A., & Gutzki, F. M. (2011). In-
source formation of N-acetyl-p-benzoquinone imine
(NAPQI), the putatively toxic acetaminophen (paracetamol)
metabolite, after derivatization with pentafluorobenzyl bro-
mide and GC–ECNICI-MS analysis. Journal of
Chromatography B, 879, 1476–1484.
Verberne, M. C., Verpoorte, R., Bol, J. F., Marcado-Blanco, J., &
Linthorst, H. J.M. (2000). Overproduction of salicylic acid in
plants by bacterial transgenes enhances pathogen resistance.
Nature Biotechnology, 18, 779–783.
Vieno, N. M., Tuhkanen, T., & Kronberg, L. (2006). Analysis of
neutral and basic pharmaceuticals in sewage treatment plants
and in recipient rivers using solid phase extraction and liquid
chromatography–tandem mass spectrometry detection.
Journal of Chromatography A, 1134, 101–111.
Wang, W. H., & Lay, J. P. (1989). Fate and effects of salicylic acid
compounds in freshwater systems. Ecotoxicology and
Environmental Safety, 17(3), 308–316.
Wei, F., Zhou, Q. W., Leng, S. Q., Zhang, L. L., & Chen, J. M.
(2011). Isolation, identification and biodegradation charac-
teristics of a new bacterial strain degrading paracetamol.
Chinese Journal of Environmental Science, 32, 1812–1819.
Winkler, M., Lawrence, J. R., & Neu, T. R. (2001). Selective
degradation of ibuprofen and clofibric acid in two model
river biofilm systems. Water Research, 3513, 3197–3205.
Wojcieszyńska, D., Greń, I., Hupert-Kocurek, K., & Guzik, U.
(2011). Modulation of FAD-dependent monooxygenase ac-
t i v i t y f r om a r oma t i c c ompound s - d e g r a d i n g
Stenotrophomonas maltophilia strain KB2. Acta Biochimica
Polonica, 58, 421–426.
Wu, S., Zhang, L., & Chen, J. (2012). Paracetamol in the environ-
ment and its degradation by microorganism. Applied
Microbiology and Biotechnology, 96, 875–884.
Zhang, L., Hu, J., Zhu, R., Zhou, Q., & Chen, J. (2013).
Degradation of paracetamol by pure bacterial cultures and
their microbial consortium. Applied Microbiology and
Biotechnology, 97, 3687–3698.
Zhou, N. Y., Al–Dulayymi, J., Baird, M. S., & Williams, P. A.
(2002). Salicylate 5-hydroxylase from Ralstonia sp. strain
U2: a monooxygenase with close relationships to and shared
electron transport proteins with naphthalene dioxygenase.
Journal of Bacteriology, 184(6), 1547–1555.
Ziylan, A., & Ince, N. H. (2011). The occurence and fate of anti-
inflammatory and analgesic pharmaceuticals in sewage and
fresh water: treatability by conventional and non-
conventional processes. Journal of Hazardous Materials,
187, 24–36.
Zwiener, C., Seeger, S., Glauner, T., & Frimmel, F. H. (2002).
Metabolites from the biodegradation of pharmaceutical resi-
dues of ibuprofen in biofilm reactors an batch experiments.
Analytical and Bioanalytical Chemistry, 372, 569–575.
Water Air Soil Pollut (2015) 226: 355 Page 13 of 13 355
